These data are consistent with the involvement of enteropeptidase in tumor cell migration and with a heparin-enhanced inhibitory effect of antithrombin on cell migration, likely mediated by modulation of enteropeptidase activity. The gene discussed is TMPRSS15; the disease is neoplasm.